Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
American Journal of Clinical Pathology|December 17, 2024
How I diagnose high-grade B-cell lymphomaErika M Moore, Sarah E GibsonHuman Pathology|August 31, 2017
J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphomaErika M Moore, Steven H Swerdlow, Sarah E GibsonThe American Journal of Surgical Pathology|January 9, 2018
Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin LymphomasErika M Moore, Steven H Swerdlow, Sarah E GibsonThe American Journal of Surgical Pathology|August 15, 2021
Mutational Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From B-lymphoblastic Neoplasms: A Multiparameter Study of a Rare and Aggressive EntityShweta Bhavsar, Yen-Chun Liu, Sarah E Gibson, et al.Living Reviews in Solar Physics|March 16, 2019
Solar prominences: theory and models: Fleshing out the magnetic skeletonSarah E GibsonAnnals of Biomedical Engineering|December 12, 2018
Harnessing Macrophages for Vascularization in Tissue EngineeringErika M Moore, Jennifer L WestHuman Pathology|January 16, 2009
Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotypeSarah E Gibson, Eric D HsiAmerican Journal of Clinical Pathology|August 19, 2020
How I Diagnose Primary Cutaneous Marginal Zone LymphomaSarah E Gibson, Steven H SwerdlowArchives of Pathology & Laboratory Medicine|May 10, 2007
Primary skull lesions in the pediatric population: a 25-year experienceSarah E Gibson, Richard A PraysonHuman Pathology|August 26, 2023
The clinical significance of increased large cells in marginal zone lymphomaTravis Stueber, Vanya Jaitly, Erika M MoorePageof 7